KINNATE BIOPHARMA INC's ticker is KNTE and the CUSIP is 49705R105. A total of 63 filers reported holding KINNATE BIOPHARMA INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $160,784 | -53.8% | 114,846 | 0.0% | 0.00% | – |
| Q2 2023 | $347,983 | -58.1% | 114,846 | -13.6% | 0.00% | – |
| Q1 2023 | $830,500 | +4.0% | 132,880 | +1.5% | 0.00% | – |
| Q4 2022 | $798,795 | -48.9% | 130,950 | +0.1% | 0.00% | -100.0% |
| Q3 2022 | $1,563,000 | -6.6% | 130,754 | -1.5% | 0.00% | 0.0% |
| Q2 2022 | $1,674,000 | +12.6% | 132,705 | +0.5% | 0.00% | 0.0% |
| Q1 2022 | $1,487,000 | -37.2% | 132,038 | -1.2% | 0.00% | 0.0% |
| Q4 2021 | $2,369,000 | -22.6% | 133,696 | +0.6% | 0.00% | 0.0% |
| Q3 2021 | $3,059,000 | +4.0% | 132,866 | +5.2% | 0.00% | 0.0% |
| Q2 2021 | $2,941,000 | +248.0% | 126,311 | +365.6% | 0.00% | – |
| Q1 2021 | $845,000 | – | 27,127 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 9,671,643 | $384,738,000 | 41.79% |
| Foresite Capital Management V, LLC | 875,001 | $34,808,000 | 25.78% |
| Vida Ventures Advisors, LLC | 2,747,074 | $109,279,000 | 22.43% |
| VR Adviser, LLC | 1,473,014 | $58,596,000 | 8.62% |
| RA Capital Management | 3,593,052 | $142,932,000 | 2.00% |
| Logos Global Management LP | 569,602 | $22,659,000 | 1.94% |
| Boxer Capital, LLC | 1,064,665 | $42,352,000 | 1.36% |
| Orbimed Advisors | 3,847,929 | $153,071,000 | 1.34% |
| HARVARD MANAGEMENT CO INC | 498,001 | $19,810,000 | 1.07% |
| DAFNA Capital Management LLC | 68,121 | $2,710,000 | 0.81% |